Menu
GeneBe

rs369697366

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_022124.6(CDH23):c.8407G>A(p.Val2803Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000818 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2803F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000068 ( 0 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

4
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 5.63
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0610072).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CDH23NM_022124.6 linkuse as main transcriptc.8407G>A p.Val2803Ile missense_variant 59/70 ENST00000224721.12
CDH23NM_001171933.1 linkuse as main transcriptc.1687G>A p.Val563Ile missense_variant 12/23
CDH23NM_001171934.1 linkuse as main transcriptc.1687G>A p.Val563Ile missense_variant 12/22

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CDH23ENST00000224721.12 linkuse as main transcriptc.8407G>A p.Val2803Ile missense_variant 59/705 NM_022124.6 P1Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152206
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000129
AC:
32
AN:
248852
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135070
show subpopulations
Gnomad AFR exome
AF:
0.000906
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000709
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.0000677
AC:
99
AN:
1461624
Hom.:
0
Cov.:
32
AF XY:
0.0000633
AC XY:
46
AN XY:
727084
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.000291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000495
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152324
Hom.:
0
Cov.:
33
AF XY:
0.000201
AC XY:
15
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.000553
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000152
Hom.:
0
Bravo
AF:
0.000212
ESP6500AA
AF:
0.000235
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000132
AC:
16
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxSep 08, 2021In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 30, 2024- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineDec 10, 2013The Val2803Ile variant in CDH23 has now been identified by our laboratory in one individual with sloping sensorineural hearing loss and in one individual with a uditory neuropathy/dys-synchrony (ANSD). However, a second pathogenic variant in CDH23 was not found in any of these individuals and pathogenic variants in CDH2 3 have not been associated with ANSD, which suggest that this variant may not be related to these individuals' hearing loss. This variant has been identified in 0.02% (1/4260) of African American chromosomes by the NHLBI Exome sequencing pr oject (http://evs.gs.washington.edu/EVS/; dbSNP rs369697366); though this freque ncy is not high enough to rule out a pathogenic role. Computational analyses (bi ochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) d o not provide strong support for or against an impact to the protein. In summary , additional information is needed to determine the clinical significance of thi s variant. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 16, 2022The c.8407G>A (p.V2803I) alteration is located in exon 59 (coding exon 58) of the CDH23 gene. This alteration results from a G to A substitution at nucleotide position 8407, causing the valine (V) at amino acid position 2803 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 1 Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.45
Cadd
Benign
20
Dann
Uncertain
1.0
DEOGEN2
Benign
0.0090
T;T;.;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.85
D;D;D;D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.061
T;T;T;T
MetaSVM
Benign
-0.93
T
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.45
T
Sift4G
Benign
0.25
T;.;T;T
Polyphen
0.84
.;P;.;.
Vest4
0.10
MVP
0.74
MPC
0.44
ClinPred
0.032
T
GERP RS
5.6
Varity_R
0.31
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369697366; hg19: chr10-73567371; COSMIC: COSV99819150; API